Delivery Order SPE2DR25D1053-SPE2DR26FT909
Award Date 11/14/25
Potential Completion Date 12/8/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,001.00 for GAMUNEX-C 5 gram/50 mL vials on November 14, 2025, with a completion date of December 8, 2025. This firm fixed-price contract is a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $9,157.05 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for GAMUNEX-C 10 gram/100 mL vials with a completion date of October 9, 2025. This firm fixed price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with a firm fixed price. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $116,360 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 8, 2025, and performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, demonstrating the contractor's ability to compete...
- The Defense Logistics Agency awarded a $3,540.39 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on July 24, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply under the company's existing indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $2,937.12 to AmerisourceBergen Drug Corp for GAMUNEX-C 1 gram/10 milliliter vials on October 8, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction for a specialized immunoglobulin product, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram, a pharmaceutical product used in federal medical procurement. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,937.12 to AmerisourceBergen Drug Corp for GAMUNEX-C 1 gram/10 milliliter vials on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $9,522.72 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials. This is a firm fixed price contract with an ultimate completion date of August 18, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,308.80 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is part of the company's...